SNYR: Synergy CHC Corp. Company Short-Term Debt

Symbol and logo of brand synergychc.com (SNYR)

Synergy CHC Corp (SNYR) generates revenue by acquiring high-demand brands within the beauty segment. Short-term debt dynamics confirm financial stability, where 0.00 characterizes this valuation parameter. Growth is driven by digital marketing coupled with outsourced production, although intensifying online competition is gradually reducing cash flow, necessitating a revision of the current promotion strategy.

SNYR (synergychc.com) Company Short-Term Debts history from 10/24/2024 to 10/03/2026

Analytical breakdowns and data insights for company Synergy CHC Corp. (SNYR)

- current quotes and average value forecast:
Price Chart Synergy CHC Corporation|SNYR - Fair Value Consensus
- market capitalization information:
Market Value Synergy CHC Corp.|SNYR - Real Price to Acquire Entire Company
- shareholders' equity book value data:
Book Value per Share Synergy CHC|SNYR - Book Capitalization|Market Cap to Net Assets Ratio synergychc.com|SNYR - Aggregate Asset Value
- debt and liquidity data:
Debt to Equity Synergy CHC Corp|SNYR - Long-Term Liabilities to Capital|Short-Term Debt to Equity Ratio Synergy CHC Corporation|SNYR - Company Cumulative Indebtedness|Debts to Book Capitalization Synergy CHC Corp.|SNYR - Company Long-Term Loans and Borrowings|Company Short-Term Debts Synergy CHC|Quick Liquidity synergychc.com
- net income and valuation multiples indicators:
SNYR - Final Profit
Summary company analytics:synergychc.com (SNYR)
Mass-produced product of Synergy CHC Corp

The stability of Synergy CHC Corp (SNYR) is underpinned by a diversified portfolio of health products, which mitigates the impact of consumer cyclicality when calculating liabilities. Analyzing the short-term debt profile with a value of 0.00, an investor assesses the total volume of payments due for repayment within a year, where the balance between liquidity and investment development directly determines the fair value of the business.

Competing companies

HLN - Company Short-Term Debt|Company Short-Term Loans and Borrowings KVUE (Kenvue Inc)|Verona Pharma Corp (VRNA) - Company Short-Term Debt|Company Current Liabilities Jyong Bio|LGND (Ligand Pharmaceuticals) - Company Short-Term Debts|Company Short-Term Debts amneal.com|Company Current Liabilities PRGO (Perrigo)|ALVO (Alvotech S.A.) - Company Short-Term Loans and Borrowings|Company Short-Term Debt Liquidia Technologies LQDA|Galapagos Corp (GLPG) - Short-Term Debt|ANIP: Company Current Liabilities|mannkindcorp.com - Amount of Current Liabilities|AMPH: Company Short-Term Debts|Pacira Pharmaceuticals - Company Short-Term Loans and Borrowings|SPRY (ARS Pharma) - Company Short-Term Debts|Short-Term Debt Theravance Corp TBPH|Company Short-Term Debt Aquestive Therapeutics (AQST)|SCPH (scpharmaceuticals.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debt Tectonic Therapeutic TECX|Short-Term Debt Volume Tonix Pharma (TNXP)|SXTC: Company Current Liabilities|Short-Term Debt Eupraxia Pharmaceuticals|BioHarvest Sciences (BHST) - Company Short-Term Debt|Company Short-Term Indebtedness EXOZ|ORMP (Oramed) - Company Short-Term Debts|Short-Term Debt Entera Bio Corp ENTX|Company Short-Term Debt MindWalk (HYFT)|ABVC (ABVC BioPharma, Inc) - Company Short-Term Loans and Borrowings|Company Short-Term Debts CPIX (Cumberland Pharmaceuticals)|Short-Term Indebtedness quantumbiopharma.com|FGEN: Company Current Liabilities|Short-Term Debt Telomir Pharmaceuticals Inc|RANI (ranitherapeutics.com) - Company Current Liabilities|Rallybio - Company Short-Term Loans and Borrowings|LEXX (Lexaria Bioscience Corp) - Company Short-Term Debts|Company Current Liabilities pulmatrix.com (PULM)|Company Short-Term Debts PTHL|APM (aptorumgroup.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debts LYRA (Lyra Therapeutics, Inc)|IBO - Company Current Liabilities|TNFA: Company Current Liabilities|Company Short-Term Loans and Borrowings YCBD (cbdMD, Inc.)|PRFX: Company Short-Term Debts|Company Current Liabilities Altamira Therapeutics Ltd.|Company Short-Term Debt Lipella|Short-Term Debt OptiNose Corp OPTN|Company Short-Term Debt Pieris Pharmaceuticals (PIRS)|PROC (procapsgroup.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debt Petros Pharmaceuticals, Inc. PTPI|QLI (Qilian International Holding Group) - Current Liabilities|SLRN - Company Short-Term Debt|Short-Term Debt Volume TFF Pharmaceuticals, Inc TFFP